Incidence of treated brain metastases among patients with stage I-III breast cancer: A population-based study
Up to 13% of patients with stage III HER2+ or TNBC received treatment for brain metastases within 5 years of diagnosis with early-stage breast cancer. These findings support prospective studies of risk-stratified screening for asymptomatic brain metastases in patients with early-stage breast cancer.
Authors
- Monika K. Kryzanowska
- Kelvin KW Chan
- Sunit Das
- Arjun Sahgal
- Refik Saskin
- Bo Zhang
- Geoffrey Liu
- Rania Chehade
- Italo Fernandes
- Hany Soliman
- Katarzyna J. Jerzak
Institutions
- Ontario Institute for Cancer Research (CA)
- St. Michael's Hospital (CA)
- Sunnybrook Health Science Centre (CA)
- University Health Network (CA)
- University of Toronto (CA)
- Princess Margaret Cancer Centre (CA)
- Institute for Clinical Evaluative Sciences (CA)
Publication Details
- Journal
- The Breast
- Published
- 2026-02-14
- DOI
- https://doi.org/10.1016/j.breast.2026.104723
- Primary Topic
- Brain Metastases and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00